Volume 70, Issue 4

Search all Cancer Chemotherapy and Pharmacology articles

October 2012

16 articles in this issue

Saccharomyces cerevisiae as a model system to study the response to anticancer agents
Renata Matuo
Fabrício G. Sousa
João Antonio Pêgas Henriques
Review Article 01 August 2012 Pages: 491 - 502
A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancer
R. Paridaens
O. Rixe
H. Roche
Original Article 04 August 2012 Pages: 503 - 511
Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled ¹⁴C material in advanced cancer patients
Sally Clive
Margaret M. Woo
Mark Kagan
Original Article 05 August 2012 Pages: 513 - 522
Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer
Jae Ho Jeong
Min-Hee Ryu
Yoon-Koo Kang
Original Article 05 August 2012 Pages: 523 - 529
A phase II study of docetaxel plus nedaplatin in patients with metastatic non-small-cell lung cancer
Koji Teramoto
Yoshikuni Asada
Shozo Fujino
Original Article 05 August 2012 Pages: 531 - 537
The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma
Han Sang Kim
Hye Ryun Kim
Byoung Chul Cho
Original Article 07 August 2012 Pages: 539 - 546
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
Joanna M. Brell
Smitha S. Krishnamurthi
Afshin Dowlati
Original Article 07 August 2012 Pages: 547 - 553
The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer
In Keun Choi
Hwa Jung Sung
Jae Hong Seo
Original Article 08 August 2012 Pages: 555 - 558
A phase I study of BMS-690514 in Japanese patients with advanced or metastatic solid tumors
Hiroshi Nokihara
Noboru Yamamoto
Tomohide Tamura
Original Article Open access 10 August 2012 Pages: 559 - 565
A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancer
Richard M. Lush
Amita Patnaik
Anthony Tolcher
Original Article Open access 10 August 2012 Pages: 567 - 574
The efficacy and safety of bevacizumab beyond first progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer: a multicenter, single-arm, phase II trial (CCOG-0801)
Goro Nakayama
Keisuke Uehara
Yasuhiro Kodera
Original Article Open access 12 August 2012 Pages: 575 - 581
A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy
Yeul Hong Kim
Kei Muro
Chung-Pin Li
Original Article Open access 12 August 2012 Pages: 583 - 590
A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer
Brendan C. Bender
Franziska Schaedeli-Stark
Manish Gupta
Original Article 12 August 2012 Pages: 591 - 601
Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases
Raffaele Addeo
Pasquale Sperlongano
Michele Caraglia
Original Article 14 August 2012 Pages: 603 - 609
Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherapy
Yang Zhang
Liping Zhao
Li Zhang
Original Article 19 August 2012 Pages: 611 - 615
Single-dose pharmacokinetic and toxicity analysis of pyrrole–imidazole polyamides in mice
Timothy W. Synold
Bixin Xi
Peter B. Dervan
Original Article Open access 21 August 2012 Pages: 617 - 625

Volume 70, Issue 4

Saccharomyces cerevisiae as a model system to study the response to anticancer agents

A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancer

Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled ¹⁴C material in advanced cancer patients

Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer

A phase II study of docetaxel plus nedaplatin in patients with metastatic non-small-cell lung cancer

The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors

The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer

A phase I study of BMS-690514 in Japanese patients with advanced or metastatic solid tumors

A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancer

The efficacy and safety of bevacizumab beyond first progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer: a multicenter, single-arm, phase II trial (CCOG-0801)

A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy

A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer

Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases

Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherapy

Single-dose pharmacokinetic and toxicity analysis of pyrrole–imidazole polyamides in mice

Navigation